Author

N. Podoltsev

Observed name: Nikola A. Podoltsev

Institutions: University of Pavia, Hospital Universitario Reina Sofía, Policlinico San Matteo Fondazione

Observed institutions: University of Pavia, Yale University, Hospital Universitario Reina Sofía, Policlinico San Matteo Fondazione

OpenAlex ID: A5038697105

S876 Gilteritinib Significantly Prolongs Overall Survival in Patients With Flt3-mutated (flt3mut+) Relapsed/refractory (r/r) Acute Myeloid Leukemia (aml): Results From the Phase 3 Admiral Trial

2019 · A. Perl, G. Martinelli, et al. · HemaSphere · 19

Ps1036 Updated Results From a Phase 1 Study of Gilteritinib in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Aml

2019 · K. Pratz, M. Cherry, et al. · HemaSphere · 3

Abstract CT321: First results of a 10-day regimen of SGI-110 (guadecitabine), a second generation hypomethylating agent (HMA) in previously untreated elderly AML who are not candidates for intensive chemotherapy

2015 · Gail Roboz, Hagop Kantarjian, et al. · Cancer Research · 3

Works count: 3

Citation count: 25

H-index: 3

I10-index: 1